These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 3318375
1. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension. Weir MR, Josselson J, Giard MJ, Warren JB, Posner JN, Lam YW, Zaske DE, Saunders E. Am J Cardiol; 1987 Dec 14; 60(17):36I-41I. PubMed ID: 3318375 [Abstract] [Full Text] [Related]
2. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension. Myburgh DP, Gordon NF. Am J Cardiol; 1987 Nov 01; 60(13):1092-5. PubMed ID: 3314458 [Abstract] [Full Text] [Related]
3. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension. Frishman WH, Zawada ET, Smith LK, Sowers J, Swartz SL, Kirkendall W, Lunn J, McCarron D, Moser M, Schnaper H. Am J Cardiol; 1987 Mar 01; 59(6):615-23. PubMed ID: 3548301 [Abstract] [Full Text] [Related]
4. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol. Luurila OJ, Gröhn P, Heikkilä J, Hämäläinen L, Härkönen R, Idänpään-Heikkilä U, Kohvakka A, Rytkönen U, Setälä M, Sundberg S. Am J Cardiol; 1987 Oct 01; 60(10):832-5. PubMed ID: 3310576 [Abstract] [Full Text] [Related]
5. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension. Nikkilä MT, Inkovaara JA, Heikkinen JT, Olsson SO. Am J Cardiol; 1989 May 15; 63(17):1227-30. PubMed ID: 2711992 [Abstract] [Full Text] [Related]
6. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension. Fermé I, Djian J, Tcherdakoff P. J Cardiovasc Pharmacol; 1990 May 15; 16 Suppl 1():S46-50. PubMed ID: 1706014 [Abstract] [Full Text] [Related]
7. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients. Chrysant SG, Miller E. Clin Cardiol; 1994 Dec 15; 17(12):670-4. PubMed ID: 7867240 [Abstract] [Full Text] [Related]
8. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension. Nikkilä M, Inkovaara J, Heikkinen J. Ann Med; 1991 Apr 15; 23(2):141-5. PubMed ID: 2069791 [Abstract] [Full Text] [Related]
11. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension. Graney WF. Am J Med; 1992 Aug 31; 93(2A):56S-64S. PubMed ID: 1519637 [Abstract] [Full Text] [Related]
19. Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. Kawanishi DT, Leman RB, Pratt CM, O'Rourke RA. Am J Cardiol; 1987 Dec 14; 60(17):29I-35I. PubMed ID: 2891291 [Abstract] [Full Text] [Related]